BPI 2026 · CDMO & CRO

Altruist Biologics at BPI 2026

Altruist Biologics brings 1 presentation to BPI 2026 in Boston, and exhibits at Booth 1027. Its session covers dual-payload bispecific antibody-drug conjugates. It sets out strategies to overcome the process and quality challenges these molecules bring, from a CDMO that spans cell line development through commercial manufacturing.

OrganizationBPI 2026 Attendance
1 Vice President, Head of Global Quality
altruistbio.com
CDMO & CROBronze sponsor
Biologics CDMO owned by Innovent Biologics, covering cell line development through commercial manufacturing, including ADCs, bioconjugation and fill-finish.
Booth
Exhibiting at Booth 1027
Wed, Sep 233:30pm–7:00pmThu, Sep 248:15am–5:00pmFri, Sep 259:00am–1:50pm
Talk
Wed Sep 23
11:45am–12:15pm
Advancing dual-payload bispecific ADCs: Strategies to overcome process and quality challenges
CMC Strategy & Manufacturing Performance

Explore the full BPI 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Altruist Biologics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction